Thanatophoric Dysplasia Type I Confirmed by Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation: Clinical Course and Ethical Considerations. This evidence concerns the gene FGFR3 and thanatophoric dysplasia type 1.